- Start of construction just one year after the official launch of the project
- Vice Chancellor Lars Klingbeil acknowledges the significance of the project for Germany as supporting environment for innovative companies
- Opening of the center…
On September 17, the World Health Organization (WHO) will celebrate World Patient Safety Day 2025 under the theme “Safe care for every newborn and every child.” As part of this global campaign, Berlin-based startup tio announces the beta launch of…
Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in “Nature Communications,” the tool, called Flexynesis, uses deep neural networks and evaluates…
Researchers led by Dubravka Vučićević at the Max Delbrück Center have developed a new method to discover how DNA controls genes. Their technique, published in “Cell Genomics,” can reveal the genetic “switches” that regulate important genes more…
ERC Starting Grants rank among the most coveted and significant European awards. Three young researchers from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) convinced the selection committee of the European…
Markus Mittnenzweig of the Max Delbrück Center has been awarded a €1.5 million grant from the European Research Council. He and his team will build dynamic 3D models of how neighboring cells and gene activity guide early-stage embryonic zebrafish…
Minister of Science Dr. Manja Schüle, visited the Fraunhofer Institute for Cell Therapy and Immunology IZI-BB at Potsdam Science Park today. The visit focused on research projects, partnerships, and future perspectives of the Fraunhofer Center for…
Prof. Surjo Soekadar heads the research division for Translation and Neurotechnology at Charité – Universitätsmedizin Berlin and is regarded as a pioneer in the field of clinical neurotechnology. In recent years, the three-time European Research…
Universal applicability of the AI model paves the way for accelerated drug discovery
Ashley Sanders has been awarded a full professorship from Charité –Universitätsmedizin Berlin. The tenured position will enable her and her team to expand their research on developing personalized therapies for inflammatory bowel disease and other…
